<DOC>
	<DOCNO>NCT00225862</DOCNO>
	<brief_summary>A 12-week clinical research study evaluate tolerability , efficacy safety ropinirole compare placebo ( inactive sugar pill ) treatment patient RLS United States .</brief_summary>
	<brief_title>A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome ( RLS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>Ã‚ Inclusion criterion : Patients diagnose Restless Legs Syndrome ( RLS ) . Patients diagnosed RLS ( symptom include overwhelming urge move legs usually accompany uncomfortable sensation legs ; usually occur rest ; bad evening night generally relieve , least temporarily , movement ) . Patients must give write informed consent prior specific study procedure . Exclusion criterion : Patients primary sleep disorder RLS . Patients symptoms secondary RLS ( i.e. , renal failure , iron deficient anemia , pregnancy ) movement disorder ( i.e. , Parkinson 's Disease ) . Other inclusion exclusion criterion evaluate physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>RLS</keyword>
	<keyword>Restless Legs Syndrome</keyword>
</DOC>